Peptide record

TPDB45705

Antiviral standard
17 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45705
Antiviral
Anti-infective peptides
DRAVP 2.0 Peptipedia
standard
No
A 17-aa standard-residue antiviral peptide sequence curated from DRAVP 2.0 and Peptipedia, with an available 3D structural model.
Sequence
LLMVNEATRFQTVSGFV
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C86H138N22O25S1
DCHIKPWY
V
1912.23
6.97
1
1
9
-0
0.55
0.700
102.94
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
5
Residue Composition
number
1
A
1
R
1
N
0
D
0
C
1
E
1
Q
1
G
0
H
0
I
2
L
0
K
1
M
2
F
0
P
1
S
2
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 1 R: 1 N: 1 D: 0 C: 0 E: 1 Q: 1 G: 1 H: 0 I: 0 L: 2 K: 0 M: 1 F: 2 P: 0 S: 1 T: 2 W: 0 Y: 0 V: 3
Chemical Descriptors
17 reviewed residue count
C86H138N22O25S1 sequence-only estimate (linear, free termini)
1912.23 sequence-only estimate (linear, free termini)
6.97 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
0.55 sequence-only estimate (linear, free termini)
0.700 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0